Evidence map›Paper›PMID 35579930›Full record

ArticleJMIR research protocols2022

Technology-Based Interventions in Substance Use Treatment to Promote Health Equity Among People Who Identify as African American/Black, Hispanic/Latinx, and American Indian/Alaskan Native: Protocol for a Scoping Review.

Emily G Hichborn, Sarah K Moore, Phoebe R Gauthier, Nico O Agosti, Kathleen D Bell, Jesse S Boggis, Chantal A Lambert-Harris, Elizabeth C Saunders, Avery M Turner, Bethany M McLeman and 1 more

Open access · goldAbstract read
In one paragraph

Article in JMIR research protocols, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.7field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Emily G Hichborn *Center for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.ORCID https://orcid.org/0000-0003-2261-1315
Sarah K MooreCenter for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.ORCID https://orcid.org/0000-0001-7402-3318
Phoebe R GauthierCenter for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.ORCID https://orcid.org/0000-0003-0259-6074
Nico O AgostiCenter for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.ORCID https://orcid.org/0000-0002-7075-2393
Kathleen D BellCenter for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.ORCID https://orcid.org/0000-0003-4150-8057
Jesse S BoggisCenter for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.ORCID https://orcid.org/0000-0002-9413-7002
Chantal A Lambert-HarrisCenter for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.ORCID https://orcid.org/0000-0002-5355-8206
Elizabeth C SaundersCenter for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.ORCID https://orcid.org/0000-0002-2728-0001
Avery M TurnerCenter for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.ORCID https://orcid.org/0000-0002-8162-678X
Bethany M McLemanCenter for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.ORCID https://orcid.org/0000-0001-5382-7114
Lisa A MarschCenter for Technology and Behavioral Health, Geisel School of Medicine, Dartmouth College, Lebanon, NH, United States.ORCID https://orcid.org/0000-0001-6429-0965
Dartmouth College · US

Funding

Project-002UG1DA040309 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2015 to 2026
$37.9M
Treatment Development & Evaluation CoreP30DA029926 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2011 to 2026
$21.5M
Training in the Science of Co-Occurring DisordersT32DA037202 · NIDA · DARTMOUTH COLLEGE · PI Lisa A. Marsch · 2014 to 2026
$4.7M
NIDA NIH HHS P30 DA029926NIDA NIH HHS T32 DA037202NIDA NIH HHS UG1 DA040309
6 · The paper itself

Abstract

backgroundTechnology-based interventions (TBIs; ie, web-based and mobile interventions) have the potential to promote health equity in substance use treatment (SUTx) for underrepresented groups (people who identify as African American/Black, Hispanic/Latinx, and American Indian/Alaskan Native) by removing barriers and increasing access to culturally relevant effective treatments. However, technologies (emergent and more long-standing) may have unintended consequences that could perpetuate health care disparities among people who identify as a member of one of the underrepresented groups. Health care research, and SUTx research specifically, is infrequently conducted with people who identify with these groups as the main focus. Therefore, an improved understanding of the literature at the intersection of SUTx, TBIs, and underrepresented groups is warranted to avoid exacerbating inequities and to promote health equity.

objectiveThis study aims to explore peer-reviewed literature (January 2000-March 2021) that includes people who identify as a member of one of the underrepresented groups in SUTx research using TBIs. We further seek to explore whether this subset of research is race/ethnicity conscious (does the research consider members of underrepresented groups beyond their inclusion as study participants in the introduction, methods, results, or discussion).

methodsFive electronic databases (MEDLINE, Scopus, Cochrane Library, CINAHL, and PsycInfo) were searched to identify SUTx research using TBIs, and studies were screened for eligibility at the title/abstract and full-text levels. Studies were included if their sample comprised of people who identify as a member of one of the underrepresented groups at 50% or more when combined.

resultsTitle/abstract and full-text reviews were completed in 2021. These efforts netted a sample of 185 studies that appear to meet inclusionary criteria. Due to the uniqueness of tobacco relative to other substances in the SUTx space, as well as the large number of studies netted, we plan to separately publish a scoping review on tobacco-focused studies that meet all other criteria. Filtering for tobacco-focused studies (n=31) netted a final full-text sample for a main scoping review of 154 studies. The tobacco-focused scoping review manuscript is expected to be submitted for peer review in Spring 2022. The main scoping review data extraction and data validation to confirm the accuracy and consistency of data extraction across records was completed in March 2022. We expect to publish the main scoping review findings by the end of 2022.

conclusionsResearch is needed to increase our understanding of the range and nature of TBIs being used in SUTx research studies with members of underrepresented groups. The planned scoping review will highlight research at this intersection to promote health equity. INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): DERR1-10.2196/34508.

Indexed as

health disparitiesscoping reviewsocial determinants of healthsubstance usetechnology-based interventionstreatmentunderrepresented

Identifiers

PMID35579930
PMCPMC9157317
OpenAlexW4280649382

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.